Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xilio Therapeutics, Inc. XLO

Set alert

Price alert · XLO

All alert types
8.72 USD +0.73 +9.09%

As of Nov 3, 12:48 PM ET

Bid
8.61 × 2
Ask
8.89 × 4
7.94 Day range 8.85
6.47 52-week range 12.01
YTD
-2.72%
1 year
-26.76%
Open
7.94
Prev close
7.99
Mkt cap
57.35M
Vol
14.10K
Avg vol
12.22K
EPS
-0.60
P/E
0.00
Div yield
0.00%
More statistics
Low
7.94
High
8.85
Forward P/E
-1.91
Beta
-0.20
Short ratio
0.42
Inst. own
29.50%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.01
200-d avg
0.970715
1y target
4.50

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 10, 2022Rating: Raymond James · — → Outperform
  • Dec 21, 2022Rating: Chardan Capital · — → Buy
  • Jan 27, 2023Rating: Morgan Stanley · — → Overweight
  • May 11, 2023Rating: Chardan Capital · — → Buy
  • May 30, 2023Rating: Chardan Capital · Buy → Buy
  • Apr 1, 2024Earnings: -0.64; estimate -0.62; surprise -3.23%
  • May 14, 2024Earnings: —; estimate -0.3; surprise —%
  • May 14, 2024Earnings: -0.59; estimate -0.3; surprise -96.67%
  • Aug 8, 2024Earnings: —; estimate -0.23; surprise —%
  • Aug 8, 2024Earnings: -0.24; estimate -0.23; surprise -4.35%
  • Nov 7, 2024Earnings: -0.22; estimate -0.25; surprise 12%
  • Nov 8, 2024Rating: Raymond James · Outperform → Outperform
  • Mar 16, 2026Split: 1 for 14
Signals (85)
NameDateAgo
SMA: BearishOct 12, 20263 weeks ago
MACD: Sell SignalOct 12, 20263 weeks ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BearishMay 18, 20265 months ago
SMA: BullishMay 11, 20265 months ago
SMA: BearishMay 4, 20266 months ago
MACD: Buy SignalMar 30, 20267 months ago
SMA: BullishMar 23, 20267 months ago
MACD: Sell SignalDec 8, 202511 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishNov 17, 202511 months ago
SMA: BearishNov 10, 202511 months ago
SMA: BearishNov 10, 202511 months ago
SMA: BullishOct 20, 20251 year ago
SMA: BullishOct 20, 20251 year ago

Newest 20 of 85.

Analyst view

Consensus: buy

Buy
Price target (mean) 4.50 -48.4% downside
Target (low)
4.00
Target (mean)
4.50
Target (high)
5.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 3
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

XLO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.24-0.24 – -0.24-0.64+62.5%00.0%1
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year-1.21-1.21 – -1.21-2.78+56.5%7.69M0.0%1
Next year-0.67-0.67 – -0.67-1.21+44.6%36.07M+368.7%1

Upgrades and downgrades

The latest rating changes

XLO analyst upgrades and downgrades
DateFirmActionFromTo
Nov 8, 2024Raymond JamesMaintainedOutperformOutperform
May 30, 2023Chardan CapitalReiteratedBuyBuy
May 11, 2023Chardan CapitalReiterated—Buy
Jan 27, 2023Morgan StanleyMaintained—Overweight
Dec 21, 2022Chardan CapitalInitiated—Buy
Nov 10, 2022Raymond JamesMaintained—Outperform
Aug 10, 2022Morgan StanleyMaintained—Overweight
Jan 10, 2022HC Wainwright & Co.Initiated—Buy
Nov 16, 2021Raymond JamesInitiated—Outperform
Nov 16, 2021Cowen & Co.Initiated—Outperform
Nov 16, 2021Morgan StanleyInitiated—Overweight